Dark

Check out our API

GBLX
GB SCIENCES INC
stock OTC

EOD

Aug 22, 2025

0.000200USD0.000%(0.000000)6,261

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 14, 2022

03:38PM EST The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More Benzinga

Jan 11, 2022

10:24AM EST Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry Benzinga

07:55AM EST Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, has closed the sale of its last remainingcannabis facility, completing a transition to the biopharmaceutical industry. GlobeNewswire Inc

Dec 6, 2021

07:00AM EST Gb Sciences Targets COVID-19 Treatment as Omicron Variant Arrives GlobeNewswire Inc

Nov 29, 2021

07:00AM EST Recognizing the glacial pace of traditional drug research and development processes and the adverse effect of this on patients, biopharmaceutical company Gb Sciences has taken innovative steps to speed up the process and is developing key relationships to further advance the clinical development of its novel, plant-inspired therapies for the prescription drug market. GlobeNewswire Inc

Nov 1, 2021

07:00AM EDT Gb Sciences Starts Preclinical Study for Plant-Based Formulas to GlobeNewswire Inc

Sep 14, 2021

07:00AM EDT Gb Sciences Achieves Positive Proof-of-Concept Results for Their GlobeNewswire Inc

Sep 9, 2021

09:54AM EDT Gb Sciences Presenting COVID-Related Cytokine Release Syndrome GlobeNewswire Inc

Share